Granted Patent B2

US 12,741,098 · App. 17/872,959 · Granted Sep 22, 2026

Inventor: Sibgat Ulla (Rensselaer, NY)

Assignee: Regeneron Pharmaceuticals, Inc.

A61M5/31536A61M5/31511A61M5/31583A61M5/31593

Abstract

Claims (53)

1 . A drug delivery device comprising:

a barrel including a proximal end and a distal end;

a plunger rod extending into the barrel through an opening at the proximal end of the barrel, the plunger rod including a projection having a proximal portion and a distal portion; and

a flange coupled to the proximal end of the barrel, the flange including a body, an opening with a circumference fully enclosed by the body, a channel, a first surface, and a second surface that is distal of the first surface, wherein the first surface and the second surface define interfaces for engaging the distal portion such that the body is only configured for two longitudinal and distally-directed strokes of the plunger rod that are inhibited by the flange;

wherein the distal portion of the projection is positioned external from the body of the flange prior to an initial stroke of the plunger rod;

wherein, after the initial stroke, the distal portion abuts the first surface such that the flange limits distal movement of the plunger rod, wherein, upon rotating the plunger rod about the central longitudinal axis, the flange allows distal movement of the distal portion of the projection relative to the channel to allow the plunger rod to move until the distal portion abuts the second surface, wherein the second surface defines a closed end of the channel, the flange is configured to inhibit distal movement and rotation of the plunger rod relative to the barrel when the distal portion of the projection is positioned against the closed end of the channel;

wherein the proximal portion of the projection is longitudinally spaced from the first surface when the distal portion abuts the second surface such that the proximal portion is positioned outside and proximal to the opening of the flange.

2 . The drug delivery device of claim 1 , wherein, prior to the initial stroke, the distal portion of the projection is spaced from the first surface of the flange by a priming distance.

3 . The drug delivery device of claim 2 , wherein the initial stroke includes advancing the plunger rod distally by the priming distance until the distal portion of the projection contacts the first surface of the flange.

4 . The drug delivery device of claim 2 , wherein upon moving the initial stroke and rotating the plunger rod about the central longitudinal axis and relative to the flange, the plunger rod is configured to move distally relative to the flange via a final stroke.

5 . The drug delivery device of claim 4 , wherein the projection is longitudinally aligned with the first surface and longitudinally misaligned with the second surface, in a direction parallel to the central longitudinal axis, upon the plunger rod moving the initial stroke and prior to rotating about the central longitudinal axis.

6 . The drug delivery device of claim 4 , wherein the projection is longitudinally aligned with the second surface and longitudinally misaligned with the first surface, in a direction parallel to the central longitudinal axis, upon rotating the plunger rod about the central longitudinal axis and moving along the final stroke.

7 . The drug delivery device of claim 1 , further comprising a plunger inside the barrel and in contact with the plunger rod;

wherein movement of the plunger rod via the initial stroke and the final stroke does not cause the plunger to contact the distal end of the barrel.

8 . A drug delivery device comprising:

a barrel including a proximal end and a distal end;

a plunger rod extending into the barrel through an opening at the proximal end of the barrel and along a central longitudinal axis of the drug delivery device, the plunger rod including a projection having a proximal portion and a distal portion; and

a flange coupled to the proximal end of the barrel, the flange including a body, a hole with a circumference fully enclosed by the body and a channel;

wherein the distal portion of the projection is longitudinally spaced apart from a first proximally-facing surface of the flange and positioned external from the flange prior to an initial stroke of the plunger rod;

wherein the flange at least partially defines a first path terminating at the first proximally-facing surface, such that the first proximally-facing surface abuts the distal portion after the plunger rod moves the initial stroke through the first path of the flange, wherein the channel is defined by a second proximally-facing surface that is longitudinally offset from the first proximally-facing surface, the channel is only configured for one stroke that is inhibited by the flange after the initial stroke that causes the distal portion to abut the first proximally-facing surface;

wherein the flange defines a second path at least partially defined by sidewalls of the channel, and terminating at the second proximally-facing surface, such that the second proximally-facing surface abuts the distal portion after the plunger rod moves a final stroke through the second path of the flange, the flange is configured to inhibit distal and rotational movement of the plunger rod relative to the barrel with the distal portion of the projection positioned against the second proximally-facing surface; and

wherein the second proximally-facing surface is configured to receive the distal portion of the projection with the proximal portion of the projection positioned outside and proximal to the hole of the flange.

9 . The drug delivery device of claim 8 , wherein the body of the flange has a one-piece construction.

10 . The drug delivery device of claim 8 , wherein the flange is a finger flange and includes a sleeve defining the first proximally-facing surface and the second proximally-facing surface.

11 . The drug delivery device of claim 10 , wherein the sleeve is integral with the flange such that the finger flange and the sleeve are a unitary body.

12 . The drug delivery device of claim 10 , wherein the first proximally-facing surface is positioned proximal to, and laterally offset from, the second proximally-facing surface.

13 . The drug delivery device of claim 8 , wherein the projection is disposed about, and protrudes in a direction perpendicular to, the central longitudinal axis of the drug delivery device.

14 . A method of preparing the drug delivery device of claim 8 for delivering a dose of a drug substance, the method comprising:

advancing the plunger rod distally into the barrel via the initial stroke until the distal portion abuts the first proximally-facing surface; and

rotating the plunger rod about the central longitudinal axis, relative to the flange, until the distal portion no longer abuts the first proximally-facing surface.

15 . The method of claim 14 , the method further comprising:

advancing the plunger rod distally into the barrel via the final stroke until the distal portion abuts the second-proximally facing surface.

16 . The method of claim 15 , wherein advancing the plunger rod via the initial stroke primes the drug delivery device, and advancing the plunger rod via the final stroke delivers the dose of the drug substance from the drug delivery device.

17 . A drug delivery device comprising:

a barrel including a proximal end and a distal end;

a plunger rod extending into the barrel, wherein the plunger rod includes a projection that has a proximal portion and a distal portion; and

a flange coupled to the proximal end of the barrel, the flange including a body, an opening, a channel, a first surface, and a second surface that is distal of the first surface, the flange is configured to receive the plunger rod through the opening and the projection through the channel;

wherein, the body is only configured for a pair of distally-directed strokes of the plunger rod that are inhibited by the flange;

wherein, when:

the distal portion of the projection is longitudinally spaced from the first surface by a first distance corresponding to a first stroke of the pair of distally-directed strokes, the distal portion is not in longitudinal alignment with the second surface;

the distal portion of the projection contacts the first surface of the flange, the distal portion is not in longitudinal alignment with the second surface of the flange;

the distal portion of the projection is longitudinally spaced from the second surface by a second distance corresponding to a second stroke of the pair of distally-directed strokes, the distal portion is in longitudinal alignment with the second surface and not in longitudinal alignment with the first surface; and

the distal portion of the projection contacts and is in longitudinal alignment with the second surface, the proximal portion of the projection is longitudinally spaced from the first surface and positioned proximal to the opening and outside the flange;

wherein the second surface defines a closed end of the channel, and the flange is configured to inhibit distal movement and rotation of the plunger rod relative to the barrel when the distal portion of the projection is positioned against the closed end of the channel.

18 . The drug delivery device of claim 17 , further comprising:

a plunger disposed inside the barrel and in contact with the plunger rod;

wherein, when the projection is in contact with the first surface and the second surface, the plunger is not flush with the distal end of the barrel.

19 . The drug delivery device of claim 17 , further comprising:

a plunger disposed inside the barrel and in contact with the plunger rod;

a first volume of drug product disposed in between the plunger and the distal end of the barrel prior to the plunger rod moving the first stroke;

a second volume of drug product disposed in between the plunger and the distal end of the barrel after the plunger rod moves the first stroke and prior to moving the second stroke, wherein the second volume of drug product is smaller than the first volume of drug product; and

a third volume of drug product disposed in between the plunger and the distal end of the barrel after the plunger rod moves the second stroke, wherein the third volume of drug product is smaller than the second volume of drug product and greater than zero.

20 . The drug delivery device of claim 17 , wherein the first distance is less than the second distance, and the plunger rod is prevented from moving distally relative to the flange after the projection contacts the second surface.

Assignments (1)

Continuity (9)

References Cited (400)